Nature Communications (Nov 2022)

Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer

  • Qiaoqi Sui,
  • Xi Zhang,
  • Chao Chen,
  • Jinghua Tang,
  • Jiehai Yu,
  • Weihao Li,
  • Kai Han,
  • Wu Jiang,
  • Leen Liao,
  • Lingheng Kong,
  • Yuan Li,
  • Zhenlin Hou,
  • Chi Zhou,
  • Chenzhi Zhang,
  • Linjie Zhang,
  • Binyi Xiao,
  • Weijian Mei,
  • Yanbo Xu,
  • Jiayi Qin,
  • Jian Zheng,
  • Zhizhong Pan,
  • Pei-Rong Ding

DOI
https://doi.org/10.1038/s41467-022-35096-6
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 11

Abstract

Read online

Inflammatory conditions often affect colorectal cancer patients, and their effect on their ongoing treatment is a pressing medical question. Here authors show that inflammation interferes with local anti-tumour immune response and inhibits response to immune checkpoint blockade therapy via immunosuppressive neutrophil leukocytes.